Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador)
- PMID: 1782081
- DOI: 10.1016/0277-5379(91)90443-h
Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador)
Abstract
We investigated alteration in DNA repair during therapy with an immunomodulator. 14 patients with advanced breast cancer were treated parenterally with Iscador, an extract of Viscum album (mistletoe). As a parameter for measurement of DNA repair the incorporation of (3H) thymidine into DNA of unstimulated lymphocytes after ultra violet light (UV) damage was taken. The DNA repair values in the patients were very low before treatment and on day 1: on average 16% of those in a healthy control population. Values started to increase on day 2 and on days 7-9 were on average 2.7 times higher than before treatment. 12/14 patients showed an improvement in repair. The values of spontaneous DNA synthesis were not altered during the treatment. We suggest that the increase of DNA repair could be due to a stimulation of repair enzymes by lymphokines or cytokines secreted by activated leukocytes or an alteration in the susceptibility to exogenic agents resulting in less damage.
Similar articles
-
Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.CMAJ. 1998 May 5;158(9):1157-9. CMAJ. 1998. PMID: 9597967 Free PMC article. Review. No abstract available.
-
Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.Altern Ther Health Med. 2001 May-Jun;7(3):57-66, 68-72, 74-6 passim. Altern Ther Health Med. 2001. PMID: 11347286 Clinical Trial.
-
Anticarcinogenic and antimetastatic activity of Iscador.Anticancer Drugs. 1997 Apr;8 Suppl 1:S15-6. doi: 10.1097/00001813-199704001-00004. Anticancer Drugs. 1997. PMID: 9179361
-
Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.Eur J Med Res. 2006 Nov 30;11(11):485-95. Eur J Med Res. 2006. PMID: 17182361 Clinical Trial.
-
Immune modulation using mistletoe (Viscum album L.) extracts Iscador.Arzneimittelforschung. 2006 Jun;56(6A):508-15. doi: 10.1055/s-0031-1296818. Arzneimittelforschung. 2006. PMID: 16927532 Review.
Cited by
-
Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications.Evid Based Complement Alternat Med. 2005 Mar;2(1):59-67. doi: 10.1093/ecam/neh058. Epub 2005 Jan 28. Evid Based Complement Alternat Med. 2005. PMID: 15841279 Free PMC article. No abstract available.
-
Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL).Trials. 2020 Sep 11;21(1):783. doi: 10.1186/s13063-020-04581-y. Trials. 2020. PMID: 32917288 Free PMC article.
-
Evaluation of Preclinical Assays to Investigate an Anthroposophic Pharmaceutical Process Applied to Mistletoe (Viscum album L.) Extracts.Evid Based Complement Alternat Med. 2014;2014:620974. doi: 10.1155/2014/620974. Epub 2014 May 4. Evid Based Complement Alternat Med. 2014. PMID: 24876872 Free PMC article.
-
Do chemo- and radiotherapy affect the DNA repair ability of lymphocytes?Arch Gynecol Obstet. 1992;251(3):121-6. doi: 10.1007/BF02718373. Arch Gynecol Obstet. 1992. PMID: 1605676
-
Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.CMAJ. 1998 May 5;158(9):1157-9. CMAJ. 1998. PMID: 9597967 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials